Additional drug shows promise for women with triple-negative breast cancer
In a nationwide study of women with "triple-negative" breast cancer, adding the chemotherapy drug carboplatin or the angiogenesis inhibitor Avastin to standard chemotherapy drugs brought a sharp increase in the number of ...
Dec 13, 2013
1
0